{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:34:56Z","timestamp":1761870896821,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.clml.2016.09.007","type":"journal-article","created":{"date-parts":[[2016,9,17]],"date-time":"2016-09-17T18:48:08Z","timestamp":1474138088000},"page":"52-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Predictive and Prognostic Implications of Variant Philadelphia Translocations in CML: Experience From a Tertiary Oncology Center in Southern India"],"prefix":"10.1016","volume":"17","author":[{"given":"Govind Babu","family":"Kanakasetty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lakshmaiah","family":"Kuntejowdahalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditi Harsh","family":"Thanky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lokanatha","family":"Dasappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linu Abraham","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suresh Babu","family":"Mallekavu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prasanna","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2016.09.007_bib1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cancergencyto.2006.10.006","article-title":"On the genesis and prognosis of variant translocations in chronic myeloid leukemia","volume":"173","author":"Gorusu","year":"2007","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.clml.2016.09.007_bib2","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJMoa011573","article-title":"Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia","volume":"346","author":"Kantarjian","year":"2002","journal-title":"N\u00a0Engl J Med"},{"year":"2013","series-title":"An International System for Human Cytogenetic Nomenclature","key":"10.1016\/j.clml.2016.09.007_bib3"},{"key":"10.1016\/j.clml.2016.09.007_bib4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3324\/haematol.12588","article-title":"Monitoring treatment of chronic myeloid leukemia","volume":"93","author":"Baccarani","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2016.09.007_bib5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1182\/blood-2006-01-0092","article-title":"Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results","volume":"108","author":"Hughes","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.clml.2016.09.007_bib6","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.1200\/JCO.2009.25.0779","article-title":"Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet","volume":"27","author":"Baccarani","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2016.09.007_bib7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Non-parametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1965","journal-title":"J\u00a0Am Stat Assoc"},{"key":"10.1016\/j.clml.2016.09.007_bib8","first-page":"185","article-title":"Asymptotically efficient rank invariant procedures","volume":"135","author":"Peto","year":"1972","journal-title":"J\u00a0R Stat Soc Ser A Stat Soc"},{"key":"10.1016\/j.clml.2016.09.007_bib9","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000046636","article-title":"Cytogenetic and molecular genetic evolution of chronic myeloid leukemia","volume":"107","author":"Johansson","year":"2002","journal-title":"Acta Haematologica"},{"key":"10.1016\/j.clml.2016.09.007_bib10","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2141.2004.04899.x","article-title":"Results of imatinib mesylate therapy in chronic myelogenous leukaemia with variant Philadelphia chromosome","volume":"125","author":"El-Zimaity","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2016.09.007_bib11","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1182\/blood-2008-03-144790","article-title":"Molecular biology of bcr-abl1-positive chronic myeloid leukemia","volume":"113","author":"Quint\u00e1s-Cardama","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clml.2016.09.007_bib12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0950-3536(97)80006-6","article-title":"Cytogenetics of chronic myelogeneous leukemia","volume":"10","author":"O'Brien","year":"1997","journal-title":"Baillieres Clin Haematol"},{"issue":"suppl 1","key":"10.1016\/j.clml.2016.09.007_bib13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3109\/10428199309047856","article-title":"The cytogenetic scenario of chronic myeloid leukemia","volume":"11","author":"Mitelman","year":"1993","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2016.09.007_bib14","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/BF00193575","article-title":"Complex translocations, simple variant translocations and Ph-negative cases in chronic myelogenous leukaemia","volume":"85","author":"Huret","year":"1990","journal-title":"Hum Genet"},{"key":"10.1016\/j.clml.2016.09.007_bib15","doi-asserted-by":"crossref","first-page":"6793","DOI":"10.1182\/blood-2011-01-328294","article-title":"Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis","volume":"117","author":"Marzocchi","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.clml.2016.09.007_bib16","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1476-4598-9-120","article-title":"Non-random distribution of genomic features in\u00a0breakpoint regions involved in chronic myeloid leukemia cases with variant t(9,22):or additional chromosomal rearrangements","volume":"9","author":"Albano","year":"2010","journal-title":"Mol Cancer"},{"key":"10.1016\/j.clml.2016.09.007_bib17","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/gcc.20196","article-title":"Breakpoints of variant 9;22 translocations in chronic myeloid leukaemia locate preferentially in the CG-richest regions of the genome","volume":"43","author":"Fisher","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"year":"1995","series-title":"Cancer Cytogenetics","author":"Heim","key":"10.1016\/j.clml.2016.09.007_bib18"},{"key":"10.1016\/j.clml.2016.09.007_bib19","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.hoc.2004.03.012","article-title":"Clonal evolution in chronic myelogenous leukemia","volume":"18","author":"Cortes","year":"2004","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.clml.2016.09.007_bib20","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1046\/j.1365-2141.2003.04291.x","article-title":"Survival implications of molecular heterogeneity in variant Philadelphia-positive chronic myeloid leukaemia","volume":"121","author":"Reid","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2016.09.007_bib21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cancergencyto.2008.01.005","article-title":"Mechanisms of genesis of variant translocation in chronic myeloid leukemia are not correlated with ABL1 or BCR deletion status or response to imatinib therapy","volume":"182","author":"Richebourg","year":"2008","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.clml.2016.09.007_bib22","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00277-012-1598-8","article-title":"Cytogenetic response to imatinib treatment in Southern Brazilian patients with chronic myelogenous leukemia and variant Philadelphia chromosome","volume":"92","author":"Koshiyama","year":"2013","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2016.09.007_bib23","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3109\/02841861003660031","article-title":"Influence of complex variant chromosomal translocations in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors","volume":"49","author":"Stagno","year":"2010","journal-title":"Acta Oncol"},{"key":"10.1016\/j.clml.2016.09.007_bib24","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1182\/blood.V98.6.1732","article-title":"Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia","volume":"98","author":"Huntly","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.clml.2016.09.007_bib25","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1200\/JCO.2009.26.7963","article-title":"Deletions of the derivative chromosome 9 do not influence the response and the outcome of chronic myeloid leukemia in early chronic phase treated with imatinib mesylate: GIMEMA CML Working Party analysis","volume":"28","author":"Castagnetti","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2016.09.007_bib26","doi-asserted-by":"crossref","first-page":"6760","DOI":"10.1182\/blood-2011-08-373902","article-title":"Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML; long-term observation of 1151 patients from the randomised CML study IV","volume":"118","author":"Fabrius","year":"2011","journal-title":"Blood"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265016305638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265016305638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:28:24Z","timestamp":1761870504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265016305638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S2152265016305638"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2016.09.007","relation":{},"ISSN":["2152-2650"],"issn-type":[{"type":"print","value":"2152-2650"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictive and Prognostic Implications of Variant Philadelphia Translocations in CML: Experience From a Tertiary Oncology Center in Southern India","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2016.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}